CD BioGlyco possesses a series of advanced research tools for the production of various Marine Biomolecules, including Marine Carbohydrates, Marine Glycoproteins, Marine Lectins, Marine Glycosides, and Marine Glycolipids. Marine creatures prove to be valuable reservoirs of new bioactive substances due to their distinctive habitat compared to land-dwelling animals. Research on marine bioactive compounds predominantly centers on a diverse array of small molecular entities showcasing a wide spectrum of chemical configurations and medicinal characteristics. Within the vast realm of marine invertebrates, sponges (Porifera) and Cnidaria (Coelenterata) emerge as primary reservoirs of natural products in terms of both the quantity and complexity of extracted compounds. In this service, we are dedicated to the extraction and production of pachymatismin, a novel glycoprotein, from sponge bioresources.
High-quality sponges as raw material will be obtained and frozen at -20°C until further use.
Thawed sponge samples will be homogenized in distilled water and centrifuged, and the supernatant will be dialyzed against distilled water followed by freeze-drying. This material serves as the starting material for purification.
After the purification steps, the next phase involves conducting various analyses to characterize the purified compound. We will perform various analyses for key parameters, including:
Journal: Marine Drugs
Published: 2017
IF: 5.4
Results: This literature review discusses the potential of compounds isolated from marine sponges as promising sources of anticancer agents. These compounds exhibit potential anticancer activity through various mechanisms, including cell-cycle arrest, anti-inflammatory activity, apoptosis, induction of ER stress, and interaction with multiple cancer-related targets. The compounds often affect multiple pathways, showcasing their multi-target nature to effectively combat the complexity of cancer. Some marine sponge derivatives demonstrate anticancer effects through particular and partially novel mechanisms, such as eribulin, which modulates microtubule dynamics differently from other antimicrotubular chemotherapy drugs. The authors mention that pachymatismin from Pachymatisma johnstonii inhibits the DU145 cell line through the target of microtubule depolymerization. In conclusion, this literature highlights the valuable research and clinical prospects of marine sponge derivatives as anticancer agents.
Can we proceed with subsequent activity assays on the produced pachymatismin?
Sure, our research team provides a comprehensive assessment of Biological Activities.
If the produced substance exhibits activity, can we perform structural modifications on it?
We provide extensive services for Modifying various marine carbohydrates by using various methodologies, expanding their applications, and supporting clients in their tissue engineering research endeavors.
With advanced biotechnological expertise and production tools, CD BioGlyco can efficiently purify and produce pachymatismin with high quality and high purity. Through our service, clients will obtain high-quality pachymatismin samples for further biological activity research and drug development. If you want to explore the potential of pachymatismin in the pharmaceutical field, please feel free to
! We are ready to provide reliable production solutions to our clients.Reference